Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 August 2020 | Story Xolisa Mnukwa | Photo Pixabay

Mental health is a crucial component for a healthy and happy life, as it directly affects how we think, feel, and behave. Mental health also determines how we manage stress, cope with challenges, relate to others, and contribute to our community.  

As noted in the University of the Free State (UFS) #WellbeingWarriors campaign, heightened negative emotions during the COVID-19 pandemic are normal. You might experience feelings of anxiety, fear, sadness, helplessness, anger, and confusion. Your thoughts can also increase negative emotions, but thoughts are not always reality. Therefore, it is best to educate yourself.

According to Dr Melissa Barnaschone – UFS Director for Student Counselling and Development (SCD), the South African Depression and Anxiety Group (SADAG) will establish and enhance the mental-health support services offered by SCD and Careways as from 1 September 2020 in the following ways: 

- SADAG will extend SCD services by offering a dedicated UFS student mental health careline, which is free and accessible 24/7 to all UFS students. This will ensure that a constant means of mental-health support is available to UFS students. 

- Careways will serve as an extension of the emergency services offered by SCD.

Dr Barnaschone further explained that SADAG is working closely with the university to assist identified students, who will benefit from longer-term counselling offered by the SCD in order to continue with their therapeutic process. SADAG will also offer further support to students while they wait for their appointments with SCD.

This helpline will provide containment, crisis intervention, and support, as well as referrals to mental-health professionals and other psychosocial resources for all students on all the UFS campuses. 
students also have the option to contact SADAG by email or SMS for counselling assistance. 

Counselling for both the SADAG and Careways services will be available in the various South African languages.

Dr Barnaschone reiterated that the SCD will continue with all the services and resources currently offered by the department, and that these additional counselling services will serve as an extension of the SCD, assisting them with patient capacity and reducing the waiting period for students to receive adequate mental-health support and counselling. 

“As we are all navigating the uncertainties and changes that are taking place within our environments, it is vital to remember that we are all human and that we are feeling overwhelmed, stressed, or anxious. We need to keep reminding ourselves and each other that this is not a hopeless situation, and when we feel that we need help, all we need to do is ask for it. We are all here to support each other,” encouraged Dr Barnaschone.



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept